Brought to you by 
Intellect licenses Wyeth, Elan Alzheimer's patents
21 Dec 2011
Executive Summary
Intellect Neurosciences (treatments for Alzheimer's and other neurodegenerative diseases) has licensed Wyeth and Elan Pharma International patents and patent applications covering the use of antibodies to treat Alzheimer's disease.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Intellect licenses Wyeth, Elan Alzheimer's patents
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice